THE INFLUENCE OF SAMPLING TIME TO SERUM GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) LEVELS IN ACUTE STROKE

Neila Raisa, Hidayat Sujuti, Masruroh Rahayu, Mochamad Dalhar
  MNJ, pp. 30-33  

Abstract


Background: Serum Glial Fibrillary Acidic Protein (GFAP) is a great potential for biomarker that is widely studied as a diagnostic biomarker of acute stroke. Sampling within 6 hours after onset is the best time window, but in Indonesia, stroke patients often arrive late more than 6 hours.
Objective: To identify the difference in time of blood sampling with serum GFAP levels within 24 hours onset of ischemic stroke (IS) patients and intracerebral hemorrhage (ICH) strokes.
Methods: Cross-sectional analysis with purposive sampling, sampling in IS and ICH strokes that arrive at the ER within 24-hour on-site. The serum GFAP examination was performed with ELISA.
Results: In this study, 41 acute stroke patients with 24-hour onset of each stroke were grouped into group 1 (<6 hours), group 2 (6-12 hours) and group 3 (12-24 hours). One Way ANOVA and Tukey's analysis showed no significant difference in GFAP levels among the three groups in both IS and ICH.
Conclusion: There was no significant difference in GFAP levels in samples <6 hours, 6-12 hours, and 12-24 hours in ischemic strokes and ICH strokes.


Keywords


GFAP; time of blood sampling; acute stroke

Full Text:

PDF

References


Saenger AK, Christenson RH. Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment. Clin Chem. 2010;56(1):21–33

Wasay M, Khatri IA, Kaul S. Stroke in South Asian Countries. Nat Rev Neurol [Internet]. 2014;10(3):135–43. DOI: http://dx.doi.org/10.1038/nrneurol.2014.13

R. R, J.L. S. Mechanical Thrombectomy Devices for Treatment of Stroke. Neurol Clin Pract. 2012;2(3):231–5

Demaerschalk BM, Cheng NT, Kim AS. Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset. The Neurohospitalist. 2015;5(3):101–9

Wechsler LR. The 4.5-hour Time Window for Intravenous Thrombolysis with Intravenous Tissue-Type plasminogen Activator is not Firmly Established. Stroke. 2014;45(3):914–5

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med [Internet]. 2018;378(8):708–18. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1713973

Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J Med [Internet]. 2015;372(24):2296–306. DOI: http://www.nejm.org/doi/10.1056/NEJMoa1503780

Pekny M, Hol EM. Glial Fibrillary Acidic Protein (GFAP) and the Astrocyte Intermediate Filament System in Diseases of the Central Nervous System. Current Opinion in Cell Biology. 2015; 32: 121-30

Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, et al. Serum Glial Fibrillary Acidic Protein as a Biomarker for Intracerebral Haemorrhage in Patients with Acute Stroke. J Neurol Neurosurg Psychiatry. 2006;77(2):181–4

Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the Diagnostic Window of Serum Glial Fibrillary Acidic Protein for the Differentiation of Intracerebral Haemorrhage and Ischaemic Stroke.

Cerebrovasc Dis. 2009;27(1):37–41

Jiang B, Ru X, Sun H, Liu H, Sun D, Liu Y, et al. Prehospital Delay and Its Associated Factors in First-Ever Stroke Registered in Communities from Three Cities in China. Sci Rep. 2016;6(February):1–11

Chadha V, Goel NK, Bhardwaj AK, Sharma A. Factors and Decisions Associated with Delayed Admission Among Stroke Patients in a Tertiary-Care Level Hospital. Indian Journal of Research. 2018;7(7): 113-5

Yang Z, Wang KKW. Glial Fibrillary Acidic Protein: from Intermediate Filament Assembly and Gliosis to Neurobiomarker. Trends Neurosci [Internet]. 2015;38(6):364–74. DOI: http://dx.doi.org/10.1016/j.tins.2015.04.003

Tykhomyrov АA, Pavlova AS, Nedzvetsky VS. Glial Fibrillary Acidic Protein (GFAP): on the 45th Anniversary of Its Discovery. 2016;48(1):54–71

Brunkhorst R, Pfeilschifter W, Foerch C. Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage-Pathophysiological Background and Clinical Findings. 2010;246–51

Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the Diagnostic Window of Serum Glial Fibrillary Acidic Protein for the Differentiation of Intracerebral Haemorrhage and Ischaemic Stroke.

;37–41

Wunderlich MT, Wallesch CW, Goertler M. Release of Glial Fibrillary Acidic Protein is Related to the Neurovascular Status in Acute Ischemic Stroke. 2006;1118–23


Refbacks

  • There are currently no refbacks.